1. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
- Author
-
Mammen, Andrew L, primary, Amato, Anthony A, additional, Dimachkie, Mazen M, additional, Chinoy, Hector, additional, Hussain, Yessar, additional, Lilleker, James B, additional, Pinal-Fernandez, Iago, additional, Allenbach, Yves, additional, Boroojerdi, Babak, additional, Vanderkelen, Mark, additional, Delicha, Eumorphia Maria, additional, Koendgen, Harold, additional, Farzaneh-Far, Ramin, additional, Duda, Petra W, additional, Sayegh, Camil, additional, Benveniste, Olivier, additional, Amato, Anthony A., additional, Biliciler, Suur, additional, Dimachkie, Mazen M., additional, Edmundson, Christyn, additional, Freimer, Miriam, additional, Geraci, Anthony, additional, Machado, Pedro, additional, Mammen, Andrew L., additional, Mozaffar, Tahseen, additional, Soltanzadeh, Payam, additional, Suresh, Niraja, additional, van der Kooi, Anneke, additional, Appleby, Matthew, additional, Barohn, Richard J, additional, Champtiaux, Nicolas, additional, Doughty, Christopher, additional, Farias, Jerrica, additional, Farmakidis, Constantine, additional, Habib, Ali A., additional, Karam, Chafic, additional, Lilleker, James, additional, Lorusso, Samantha, additional, Pasnoor, Mamatha, additional, Querin, Giorgia, additional, Raaphorst, Joost, additional, Ransley, George, additional, Saba, Sami, additional, Sheikh, Kazim, additional, Snedden, Andrew, additional, Statland, Jeffrey, additional, and Vu, Tuan, additional
- Published
- 2023
- Full Text
- View/download PDF